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1. ABSTRACT 
 
 
Isd11 is an 11kDa protein present only in Eukarya and involved in the biogenesis of iron-
sulfur clusters. Like for the other proteins associated to this machinery, its depletion or 
mutation is a potential cause of severe neurodegenerative diseases (i.e. Friedreich’s ataxia). 
In conjunction with Nfs1 it fulfils the role of cysteine desulfurase, however its precise 
function is still unclear. Literature is rather lacking of information about its structure, 
above all because it is well-known to be quite unstable if expressed in isolation.
 
The final aim of this project was to produce Isd11 and to study its state of aggregation, as a 
first step for a further characterization and comprehension of its biological function. 
Isd11 production was optimized in order to find a way to obtain pure protein despite its 
tendency to express in Bacteria in insoluble aggregates (inclusion bodies) and to degrade. 
It was cloned in three different vectors (plasmids), using DH5α as host cells, and expressed 
under different experimental conditions, in two types of engineered E.Coli cells (BL21 and 
Rosetta competent cells) to prevent problems of rare codons (triplets of nucleotides that are 
not easily translated or not translated at all by one type of cell, since not usually present in 
its own DNA). 
Degradation was overcome by cloning and expressing an Isd11 ortholog from a 
thermophilic filamentous fungus. This pathway appeared to be promising. 
Human Isd11 was purified from pellet with affinity chromatography and gel filtration and 
characterized by NMR, CD, analytical gel filtration and SEC-MALS. According to results 
obtained from gel filtration coupled to multiangle light scattering and according to the 
value of correlation time (obtained from relaxation time constants T1 and T2 of its 2D 
1
H,
15
N NMR spectrum) Isd11 was found to be in solution mainly as a dimer. CD spectra 
and thermal unfolding curves showed that, despite proteolytic degradation related to its 
expression in vivo, the protein is relatively thermally stable, but its unfolding process is not 
reversible under the considered experimental conditions. 
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2. INTRODUCTION 
 
2.1. Iron-sulfur cluster 
2.1.1. Structure and function 
Protein-bound iron-sulfur are one of the most common prosthetic groups in biology.
1
 
These groups were originally discovered in the 1960s as catalytic centres of enzymes 
participating in photosynthesis.
2
 Since then they have been found in all living organisms.
 
Iron-sulfur clusters consist essentially of polynuclear combinations of iron cations (Fe
2+ 
or 
Fe
3+
) and sulfide anions (S
2−
). The most common ones are [2Fe–2S] and [4Fe–4S] clusters 
in which iron ions are linked to each other through a sulfide bridge. As a result of that, 
these clusters can show a rhombic or cubic shape, respectively (fig. 2.1). A variant of the 
latter kind of cluster lacking one iron in one corner of the cube ([3Fe-4S]) can be observed: 
it is readily formed by oxidation but it is found rarely in nature, probably because oxidation 
can also destroy iron-sulfur cluster, unless they are protected by bulky and hydrophobic 
ligands. Iron-sulfur clusters are inherently labile in free form indeed and once produced, 
they have to be rapidly loaded onto proteins.  
The binding of the Fe-S clusters to the polypeptide chain occurs through the coordination 
of the positively charged iron ions with electron donors provided by various amino acid 
side chains.
5
 The most typical and widely used example is the sulfur of cysteine residues, 
although non-cysteinyl ligands, such as nitrogen of histidine, arginine, lysine, serine and 
water, are occasionally observed.
6 
 
Figure 2.1 
Structure of [2Fe–2S], [4Fe–4S] and [3Fe-4S] clusters 
 
In biology, iron-sulfur clusters are basically ubiquitous co-factors of proteins involved in 
several fundamental cellular processes.
4
 The ability to delocalize electron density over both 
 6 
 
iron and sulfur
7
 makes them ideally suited for their primary role in mediating biological 
electron transport, since they can access various oxidation states (fig. 2.2). 
 
 
Figure 2.2 
Oxidation states of [2Fe–2S], [4Fe–4S] and [3Fe-4S] clusters 
 
Whereas the [2Fe–2S] and [3Fe–4S] clusters are mostly used in one-electron transfer  
reactions, a much more diversified chemistry is carried out by the [4Fe–4S] clusters.3 A 
wide array of further tasks has been demonstrated or postulated, including proton transfer, 
substrate binding and activation, regulation of enzyme activity and gene expression, 
sensing of reactive species, radical generation, disulfide cleavage and sulfur donation.
4 
For 
instance, they can serve as active sites of enzymes, since they can shift electrons within the 
cluster structure, including ligands, leading them to polarization. They can also regulate 
gene expression because a reversible interconversion makes them sensors of redox 
reaction. Finally, their sensibility to oxidative degradation is exploited in sensing 
signalling.
 3 
 
2.1.2. Biosynthesis 
Iron-sulfur clusters are believed to constitute one of the most ancient types of prosthetic 
groups. Before the Great Oxygenation Event, in the early Paleoproterozoic Era,  
spontaneous formation of Fe–S clusters was likely to take place easily under anaerobic 
conditions due to the high abundance of both iron and sulfur and their propensity to 
 7 
 
coordinate with each other. Then, with a global shift to an aerobic environment, cells 
adapted to assemble these oxygen-sensitive clusters and rapidly load onto suitable 
proteins.
10
  
In agreement with this hypothesis, biosynthesis of iron-sulfur cluster appears to be widely 
conserved among almost all organisms.
3 
However the spontaneous incorporation of clusters into their protein partners is not 
compatible with the physiological toxicity of iron and sulfur. A reasonable possibility is 
that both iron and sulfur are delivered to apo-[Fe-S] proteins (Fe-S proteins lacking of Fe-S 
cluster) by specific carrier proteins that sequester them in non-toxic forms. In fact the 
biosynthesis of iron-sulfur proteins is a multistep process involving several specialized 
proteins that mediate both formation and delivery to acceptor proteins,
11-13 
which can be 
basically considered the two main steps of such biogenesis. 
Organisms have developed multicomponent systems which are widespread and highly 
conserved among Prokarya and Eukarya. While n prokaryotes a few operons encode 
cluster assembly genes, in eukaryotes homologous proteins are nuclearly transcribed. 
 
Biosynthesis in Bacteria 
Overall, three distinct operons have been observed among bacteria: the nitrogen-fixation 
(NIF), the iron-sulfur cluster (ISC) and the sulfur mobilization (SUF) machinery.
3,14
 The 
first is specifically required for the conversion of the complex [Fe-S]-nitrogenase, which in 
responsible for the conversion of N2 to NH3 in nitrogen-fixing bacteria.
15
  
The other two systems seem to operate on a wider range of proteins: the second one is 
involved in the generation of the majority of the cellular iron-sulfur protein under 
physiologic conditions,
16
 the third one prevails only when cells are subjected to iron 
starvation or oxidative-stress conditions, being, otherwise, of minor contribution.
17  
Escherichia coli in which the entire ISC operon was deleted showed an activity of Fe-S 
proteins 90-98% lower than wild-type cells, with the residual activity ascribable to the SUF 
system.
23 
Besides it seems that the ISC system is inactivated by ROS, while SUF is better 
at getting iron when this element is scarce and in harsh environmental conditions.
 
ISC is 
commonly considered the house-keeping system and SUF the stress-response dedicated 
one.
19
 
It is interesting to note that ISC is mainly
 
present in eubacteria and most eukaryotes 
whereas SUF is
 
found in plants, other bacteria and archaea. Considering that the ability to 
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acquire iron and to
 
resist oxidative burst are determining properties for bacterial
 
initiation 
of infection, the SUF system, which has a lower sensitivity toward oxygen compared to 
ISC’s one, is presumed to play a key role in the pathogenicity of bacteria like 
Mycobacterium
 
tuberculosis.
18 
All these different machineries, NIF, ISC and SUF, have in
 
common the involvement of a 
cysteine desulfurase which allows the utilization of L-cysteine
 
as a source of sulfur atoms.
3 
In addition, they
 
all contain scaffold proteins
 
which provide an intermediate
 
assembly site 
for Fe–S clusters or their precursors, from which these inorganic species can be donated to 
apoproteins (fig. 2.3).
 
 
Figure 2.3 
Scheme of synthesis and transfer of Fe-S cluster from a scaffold protein to apoproteins in ISC and 
SUF machineries; in both systems sulfur donation to the scaffold protein involves a cysteine 
desulfurase 
 
Biosynthesis in Eukarya 
Eukaryotic iron–sulfur clusters have been localized in the mitochondria, cytosol, 
endoplasmic reticulum and nucleus.
8,9
 
In each of these compartments molecules participating in Fe-S protein maturation have 
been found, suggesting that, at least in theory, biosynthesis could be achieved in all of 
them. However it has been proposed that the mitochondrial ISC-type machinery has a 
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predominant role and is required also for the biosynthesis of cytosolic and nuclear Fe–S 
proteins:
20-21
 a mitochondrial ISC-export machinery contributes to this task and the 
cytosolic iron-sulfur cluster assembly (CIA)  machinery seems to accomplish the 
assemblage of Fe-S proteins
 
(fig. 2.4).
12
 
 
 
Figure 2.4 
It seems that mitochondrial ISC-type machinery contributes somehow to the biosynthesis of cluster 
in mitochondria, nucleus and cytosol as well
 
 
Several mitochondrial proteins share high sequence similarity to the bacterial proteins of 
ISC system.
9 
It is likely that the mitochondrial ISC machinery was inherited from the 
endosymbiontic bacteria ancestor of these organelles. The SUF machinery has been found 
so far only in photosynthetic eukaryotes. The reason is not known but the low oxygen 
content inside the matrix might have favoured the conservation of the oxygen-sensitive 
ISC system.
22 
The current extensive knowledge of sulfur’s source and proteins involved in its transport in 
Eukarya will be deeply discussed later.  
The font of iron for cluster formation is less clear. Iron is taken up by mitochondria in a 
reduced form and its uptake requires an energised inner membrane and some mitochondrial 
carriers (called Mrs3 and Mrs4) to get into. It is unknown in which form it is exchanged 
and stored in mitochondrial matrix before its use in cluster. Once into mitochondria, iron 
may be delivered to the scaffold protein by Yfh1, the yeast homologue of frataxin, which 
 10 
 
was found to be necessary for transient Fe-S cluster assembly on Isu1
66
 and to be able to 
bind and oxidise iron. It is still debated if this binding is specific or not.
51 
The chemistry of cluster formation on scaffold proteins (IscU-type) is far from being 
understood. Experiments with purified bacterial proteins have led to the conflicting 
interpretation that either sulfur or iron initially bind to the Isu (or bacterial IscU or NifU) 
proteins.
51
 
It has been shown that the bacterial IscU or NifU can assemble both [2Fe–2S] and [4Fe–
4S] clusters and that these clusters can be then specifically transferred to appropriate 
apoproteins.
67 
 
2.1.3. Isc system  
In E. coli the isc operon encodes in the following order: a regulator (IscR), a cysteine 
desulfurase (IscS), a scaffold (IscU), an A-type protein (IscA), a DnaJ-like co-chaperone 
(HscB), a DnaK-like chaperon (HscA), a ferredoxin (Fdx) and IscX (or yfhj or ORF3)  
(fig. 2.5).
24
 
 
 
Figure 2.5 
Schematic representation of the Isc system in E. coli 
 
IscR 
IscR has been suggested to act as a regulator. It senses the capacity of the cell to produce 
mature Fe-S proteins and regulate their production through a negative feedback 
mechanism: low levels of mature IscR (with a [2Fe-2S] cluster) and therefore elevated 
levels of apo-IscR reflect a reduced efficiency of Fe-S cluster biogenesis and it is corrected 
by synthesizing both Isc and Suf proteins.
25
 Only after the complete satisfaction of the 
 11 
 
cellular demand for clusters, IscR acquires an iron-sulfur cluster via the Isc system and the 
isc operon is repressed again. Such regulation implies that the Isc system is able to 
distinguish between apo-IscR and other apo-protein targets: this is probably due to the 
atypical ligation scheme of the [2Fe-2S] cluster on IscR through three cysteines and one 
histidine, (Cys)3(His)1, which makes IscR a poor substrate for Isc proteins. 
Besides it has been reported that the isc operon is more repressed under anaerobic 
conditions rather than aerobic ones.
26
 In the latter case Fe-S clusters are continually 
damaged or destroyed, so a higher rate of turnover in cluster synthesis is required; on the 
contrary, in absence of oxygen, an increased concentration of iron-sulfur clusters and of 
[2Fe-2S]-IscR brings to an increased repression of isc operon, as schematically shown in 
figure 2.6. 
 
 
Figure 2.6 
Regulation of Fe-S cluster synthesis by IscR in anaerobic (left) and aerobic (right) conditions 
 
IscS 
IscS is a cysteine desulphurase, a pyridoxal-phosphate (PLP)-dependent enzyme which 
gains a sulfur atom from the degradation of L-cysteine into L-alanine.
27 
Its function will be 
widely discussed later. 
 
IscU 
It is likely that IscU acts as a scaffold for the assembly of clusters, accepting sulfur from 
IscS and iron from another component, suggested to be CyaY in bacteria and frataxin in 
 12 
 
eukaryotes.
28
 It forms a heterotetramer with desulfurase and sulfur transfer occurs from a 
cysteine on IscS to IscU, as it has been demonstrated both in vitro and in vivo.
31
 
IscU has one of the most conserved protein sequences in nature
29
 and in particular it 
contains three conserved cysteine residues that allow to accommodate both [2Fe-2S] and 
[4Fe-4S] clusters,
30
 validating its hypothesized role. 
 
IscA 
Highly conserved among species, IscA’s role is yet unclear. Since it binds Fe-S clusters 
and transfer them to a wide range of protein targets, it was initially proposed as a 
scaffold.
32
 But it does not interact with cysteine desulphurase and nowadays the most 
widely accepted hypothesises are that it carries clusters from scaffolds to apo-proteins or 
that at least it is an intermediate carrier, since it has been observed that clusters can be 
transferred from IscU to IscA but not the reverse.
33
 
It has also been proposed as an iron donor for cluster assembly on IscU
34
 and in particular 
as a chaperone to recruit intracellular iron for the cluster biosynthesis under aerobic 
conditions.
35
 Under anaerobic conditions iron is easily available and it does not require a 
chaperone. Severe effects were observed on the growth of  Azotobacter vinelandii lacking 
IscA gene only at elevated oxygen levels.
36
 It is likely that this is its main role when 
sulphide/L-cysteine is limited in cells; when they are abundant, IscA could be bifunctional 
and could act as an alternative scaffold.
37 
 
HscA and HscB 
HscA (Hsc66) and HscB (Hsc20) are suggested to be a chaperone and a co-chaperone 
respectively, similar to the prokaryotic DnaK/DnaJ and to the eukaryotic hsp70/hsp40.
38 
HscA may assist in iron-sulfur biosynthesis by inducing and maintaining IscU in a suitable 
conformation or it may promote the transfer of the cluster from IscU to an apo-protein in 
an ATP-dependent manner.
39
 
 
Formation of a 1:1:1 HscA-HscB-holoIscU complex and a single ATP hydrolysis step are 
enough to induce the activation effect of the chaperones, which could be due to the 
formation of the ternary complex itself or could occur during T to R transition of HscA 
associated to ATP hydrolysis.
40
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It has been postulated that ATP and the consequent conformational change are strictly 
required for such a HscA-mediated catalysis; its mutant form lacking ATPase activity was 
demonstrated to unable to accelerate cluster transfer.
40 
HscB controls the association between HscA and IscU by directly interacting with IscU 
and delivering it to the chaperone. The co-chaperone further stabilizes the chaperone-
scaffold complex by enhancing ATPase activity: the low affinity chaperone-ATP complex 
is converted to the higher affinity complex with ADP.
39
 (fig. 2.7) 
 
 
 
Figure 2.7 
Suggested mechanism of HscB-HscA activation of cluster transfer from IscU through both the 
formation of a ternary complex and an ATP hydrolysis 
 
Fdx 
Present in all organisms, ferrodoxin (Fdx) contains a [2Fe-2S] cluster in E. coli. 
Genetic analyses have showed that it has an essential role: bacterial strains lacking Fdx or 
with mutation in fdx gene present Fe-S containing proteins with a dramatically decreased 
activity.
41
 It has been suggested a key role as part of an electron transfer chain, providing 
electrons for the reduction of sulfur, obtained from cysteine, to sulphide S
2-
 (that is how it 
is needed in clusters). However other functions in biogenesis have not been excluded. 
 14 
 
It has also been pointed out that the bacterial ortholog of frataxin (CyaY) and ferrodoxin in 
its holo-form (apoprotein combined with its prosthetic group) compete for the same 
binding site on IscS.
42
 The reasonable question of whether they have antagonising roles has 
been validated by various observations: in the absence of holo-Fdx, CyaY inhibits the 
action of IscS on IscU; increasing concentration of holo-Fdx progressively attenuates such 
inhibition.
43
 On the contrary its concentration has an insignificant effect in the absence of 
CyaY. 
   
IscX (Yfhj or ORF3) 
IscX is a small protein, whose function has not been identified yet. It seems to compete 
with CyaY in binding to IscS,
44-45
 with which it forms a low-affinity but stable complex. 
Such affinity is modulated by the presence of iron cations, so it has been suggested that 
IscX could be a molecular adaptor (a signal transducing molecule) that mediates the 
interaction of IscS through an iron-mediated mechanism.
45 
Its encoding sequence is not present in superior organisms: it is likely that it has been 
substituted by another protein or that it represents a primitive requirement of certain 
species, no longer necessary in eukaryotes. Moreover, mutations of its gene does not show 
any relevant phenotype, making hypothesis about its behaviour more difficult. 
 
 
2.2. IscS 
Cysteine desulfurases are pyridoxal-phosphate (PLP) dependent enzymes that catalyse the 
decomposition of the L-cysteine substrate to L-alanine and sulfane sulfur.
46
 They all are 
characterized by a yellow colour due to the presence of PLP.  
The sulfur atom released from L-cysteine substrate is transferred to a widely conserved 
cysteinyl residue on the desulfurase in order to generate a protein-bound persulfide 
intermediate that could directly transfer its sulfur atom to target molecules or be reduced to 
release sulphide in solution.
3
 The formation of persulfide is how cells mobilize activated 
sulfur in a controlled way: an efficient mechanism to make sulfur available, preventing its 
release in solution. 
Cysteine desulfurases have quite similar primary structures: based on some differences of 
sequence in four particular regions, they can be classified into two main groups, I and II.
46
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The former one includes IscS/NFS/NifS enzymes, the latter one SufS/Cp(chloroplast)NifS. 
Each cysteine desulfurase can be involved in the biosynthesis of a variety of sulfur 
containing-compounds (not only in the one of Fe-S proteins)
43
 and in cellular iron 
homeostasis as well
 
(fig. 2.8).
48 
 However most of the growth defects caused by deletion of 
IscS in E.coli can be directly linked to issues in Fe-S cluster assembly.
44,47 
 
Figure 2.8 
Schematic representation of functions in which cysteine desulfurase is or may be involved 
 
For the A. vinelandii homologue of IscS, NIFS, it has been proposed the formation of the 
an aldimine Schiff base between the cysteine of the substrate and PLP. A cysteinyl thiolate 
anion, generated in situ in the active site, makes a nucleophilic attack on the sulfur of the 
cysteine-PLP adduct, giving the cysteine persulfide (from which the sulfur containing-
compounds biogenesis can start) and an enamine derivative of alanine,
49 
as shown in figure 
2.9. 
 
 
Nfs1 and Isd11 
Components of the eukaryotes ISC machinery may be derived from their prokaryotic 
counterparts, in particular from the endosymbiont that gave rise to the mitochondria.
12 
This 
could probably explain why they still primarily or exclusively localise into mitochondria.
50 
 16 
 
Similarly to bacteria, Fe-S cluster biogenesis starts with the abstraction of sulfur from free 
cysteine to form a protein-bound persulfide intermediate, with subsequent transfer to the 
scaffold protein, and then to apoproteins. In vivo studies in yeast have shown that Isu1 (and 
presumably Isu2 too) fulfils scaffold function in michondria.
21 
 
  
 
Figure 2.9  
Proposed mechanism of desulfurazation of L-cysteine substrate by NIFS, the A. vinelandii, 
homologue of IscS 
 
In Eukarya, the PLP-dependent cysteine desulfurase was identified to be Nfs1,
51
 named 
after NifS of nitrogen-fixing bacteria to underline a certain degree of sequence similarity 
between them, even if the function of NifS as desulfurase
49
 was suggested only after the 
discovery of Nfs1; later the same role was attributed to IscS from E. coli as well.
52 
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NifS in Thermotaga maritime has been the first NifS-like protein whose crystal structure 
has been reported, at a resolution of 2.0 Å:
53
 basically it is a dimer of two identical 
subunits, each one made of a small and a large domain. The PLP cofactor is attached 
through a Schiff base linkage to a conserved lysinil residue, the catalytic cysteinyl residue 
resides in the middle of a 12-residue-long highly flexible loop and finally a conserved 
histidine, suggested to be an acid/base catalyst, is on the top of PLP. The above-described 
area is shown in figure 2.10. 
 
Figure 2.10 
Representation of the catalytic site of the crystal structure of Thermotaga maritime NifS 
 
Later, the crystal structure of E. coli IscS was reported, at a resolution of 2.1Å.
54 
Until recently, Nfs1 was thought to catalyse sulfur delivery to the Isu scaffold protein by 
itself. Two independent groups reported in 2006 that Saccharomyces Cerevisiae Nfs1 
require a small (11 kDa) protein called Isd11 to fulfil its function.
55-56
  
Comparative genomic analysis showed that Isd11 is exclusively present in eukaryotes, 
implying that it is a supplement to the bacterium-derived ISC machinery.
57
 
In addition to their central role as desulfurase in Fe-S cluster biosynthesis, both Nfs1 and 
Isd11 seem to be involved in the regulation of iron metabolism: depletion of Nfs1
58
 or 
Isd11
55
 in yeast cells showed an increase of mitochondrial iron content, which is usually 
associated with some human diseases. It is well-know the double-edged nature of iron in 
biological systems, due to its further catalytic role towards Fenton reaction which 
generates highly toxic hydroxyl radicals.
59
 
His Lys 
Cys 
PLP 
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Native Nfs1-Isd11 from yeast is estimated to be about 180-200 kDa in size,
56
 but the exact 
molecular and structural function of Isd11 as a binding partner of Nfs1 remains elusive.  
Recombinantly produced yeast Nfs1, both in isolation and in complex with yeast Isd11, in 
E. coli has been studied in order to elucidate the role of Isd11.
50
 Interestingly, if incubated 
for several hours with L-cysteine, Nfs1 precipitated only when in isolation, suggesting a 
possible effect of stabilization operated by Isd11. 
Far-UV CD spectroscopy has indicated a decrease in helical content and an increase in the 
strand one of Nfs1 when in complex with Isd11 (from α: 56% β: 13%, as it has been both 
estimated and showed by X-ray crystallography, to 20% and 28%, respectively).
50
 
Although secondary-structure prediction tools suggest a predominantly α-helical nature of 
Isd11,
57
 there is the possibility that it adopts a β-stranded conformation. But, according to 
the suggested stoichiometry of the complex (1:1) and to the five-time smaller dimension of 
Isd11, its contribution to the signal would be not sufficient to justify such changes in the 
far-UV CD spectrum. A substantial rearrangement of Nfs1 subunits in its Isd11-bound 
form has been proposed as an explanation.
50 
 
Through quantitative amino acid analysis of the whole complex, it appears that Nfs1 most 
likely interacts with Isd11 in a molar ratio of 1:1, in a trimer of the Nfs1-Isd11 
heterodimer, whose existence was confirmed by size exclusion chromatography (180-
200kDa).
50
 
The Isd11-binding-induced Nfs1 oligomerisation phenomenon is in agreement with the 
observed CD spectroscopic changes, which suggests a substantial change in the 
architecture of the Nfs1-Isd11 complex compared to Nfs1 alone. This may represent a 
remarkable control of the activity of Nfs1 compared to bacterial cysteine desulphurases.  
It could be interesting to compare the situation of desulfurase in eukaryotes with a similar 
complex in the bacterial or plastid SUF systems,
61
 where Nfs1 homologue SufS binds to a 
small protein, SufE. This latter transiently receives the sulfur released by SufS before 
further transfer it to the scaffold protein, SufA, and binds it via a persulfide group formed 
on a conserved cysteine residue. However, since Isd11 does not contain any cysteine, the 
functional mechanism must be different and it could be possible that it does not bind sulfur 
at all.
60
 
In eukaryotes and in human cells in particular, the cysteine desulfurase is located mainly in 
mitochondria, with only minor amounts in the cytosol and nucleus.
62
 Cell biological 
studies have shown a situation strikingly similar to yeast:
21
 the mitochondrial version of 
 19 
 
Nfs1 is indispensable for Fe-S protein maturation both inside and outside mitochondria.
63
 
Human Nfs1-depleted cells showed defects in cell growth and mitochondrial/cytosolic Fe-
S proteins activities, which persist even in presence of murine Nfs1 deprived of the 
mitochondrial targeting sequence. These results imply the essential role of human 
mitochondrial Nfs1 for biogenesis of both mitochondrial and cytosolic proteins. Although 
no independent role of neither the cytosolic nor the nuclear version of the enzyme has been 
identified, a participation of extramitochondrial Nfs1 in addition to the one of 
mitochondrial Nfs1 cannot be excluded.
60 
Another function of Nfs1 in the cytosol or nucleus has been discussed: pioneering genetic 
studies on IscS
64
 have shown its requirement as a sulfur donor also for thiouridine 
modification of tRNA. Later the same essential task has been confirmed for yeast Nfs1,
65
 
both mitochondrial and cytosolic/nuclear. The human one could play a similar role, but 
further investigations have to be carried on. 
Finally, in addition to Nfs1, Isd11 and Yhf1/frataxin, other two components are required 
early in biogenesis: the ferrodoxin Yah1 and the ferredoxin reductase Arh1, that form an 
electron transfer chain, taking electrons from NADH and transferring them to the sulfur 
moiety released from cysteine desulfurase, in order to generate the sulfide present in Fe-S 
cluster by reduction.
68
 Even if not proven and not completely clear how it works, such role 
is likely to happen. It is not excluded that they could have a further function at a later step 
of biogenesis, for instance during the transfer of the cluster to the acceptor apoproteins, 
since it has been suggested that Yah1 is also able to carry a [2Fe-2S] cluster itself.
60
 
 
 
2.3. Isd11: state of the art 
Isd11 is an 11 kDa protein with a main mitochondrial localitation,
70
 whose homologs have 
been found throughout the Eukarya but not in Prokarya (fig. 2.11). This is unprecedented 
for an ISC-assembly component because so far all subunits are either derived from the 
bacterial isc operon or possess homologs in bacteria.
 56 
Isd11 is assigned to the LYR family, which is named because of the presence of a 
conserved leucine–tyrosine–arginine (LYK) tripeptide motif near the N-terminus of its 
protein members.
51
 This classification does not provide any information about function. 
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Figure 2.11 
Amino acid sequences of Isd11 homologue in some eukaryotes (Sc: Saccharomyces cerevisiase Sp: 
Saccharomyces pombe Yl: Yarrowia lipolytica At: Arabidopsis thaliana Dm: Drosophila 
melanogaster Mm: Mus musculus Hs: Homo sapiens) 
 
 
As stated above, Isd11 has been proposed to act as an adaptor and stabilizer of Nfs1.
55-56 
Isd11 and Nfs1 form together a stable complex of about 200 kDa that is suggested to 
represent the active mitochondrial desulfurase: in isd11 mutant mitochondria, where the 
complex is not created, Nfs1 alone is enzymatically active as a desulfurase in vitro, but 
such activity is significantly smaller than the physiological one.
56
  
To obtain evidence for the role of Isd11 in vivo, the above isd11 mutant mitochondria have 
been compared with wild-type ones: Nfs1 expressed in the former cells has been found to 
aggregate (generating inclusion bodies)
56,69 
and eventually to degrade if exposed to a heat 
shock,
56
 confirming that its small partner protein is able to facilitate its correct folding and 
stabilize it. 
The role of Isd11 in cluster biogenesis has been underlined by the fact that, in isd11 mutant 
mitochondria, only Fe-S proteins show a 75-95% diminished activity.
56
 Isd11 is now 
effectively considered a component of the mitochondrial ISC-assembly machinery. 
As a result of that, it is comprehensible why isd11 mutant cells (both human
69 
and yeast
56
 
ones) display a defect in cellular iron homeostasis:
 
yeast cells depleted of Isd11 have been 
found to contain a three-fold higher amount of iron than wild-type ones. Accumulation of 
iron within mitochondria is normally observed in mutants in the ISC-assembly and ISC-
export systems.
20
 
Analysis of the subcellular localization of human Isd11 revealed that it is present in 
abundance in  mitochondria, as expected, but also in the nuclear compartment,
69
 unlike in 
yeast, where Isd11 was found only in mitochondria.
56 
Other members of the human ISC machinery are present in two distinct isoforms that target 
to either the mitochondrial or cytosolic/nuclear compartments because they either contain 
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or lack the mitochondrial signal peptide. This fact has led to the hypothesis that the 
mitochondrial ISC machinery was duplicated in the cytosolic/nuclear compartment of 
human cells to synthesize Fe–S clusters for extra-mitochondrial Fe–S proteins.71 
Even though Isd11 was not found in the nuclear/cytosolic compartment of yeast, Nfs1 is 
actually both a mitochondrial and nuclear protein in yeast. 
Since an alternative transcript that encodes the nuclear form of Isd11 has not been found, it 
is not simple to evaluate the role of Isd11 in nuclear/cytosolic Fe–S biogenesis. There are 
several possible functions:
69
 apart from those similarly carried out in mitochondria, such as 
cluster assembly and signal transducing/stabilization of desulfurase, several bits of 
evidence imply that nuclear Fe–S proteins are important to maintain of the integrity of the 
mammalian genome.
72
 
It has been proposed that Isd11 is an essential protein of the mitochondrial matrix loosely 
associated with the inner membrane. Since it seems to be sensitive to the action of protease 
only after sonication, when the matrix is open, it could be either a matrix protein or an 
inner membrane protein accessible from the matrix side only; the lack of the hydrophobic 
transmembrane segment brings to the conclusion that it cannot be an integral membrane 
protein.
56 
Finally, as regard structure of Isd11, literature is quite lacking of information: although 
secondary-structure prediction tools point to a predominantly α-helical nature,57 the 
possibility that Isd11 may adopt a β-stranded conformation exists, as already stated.50 
 
 
 
2.4. Aim of the thesis 
Despite the shortage of information about structure, distribution in cells and exact function, 
what is sure is that Isd11 has a role in the ISC machinery. Like for the other players of the 
system, its depletion or mutation could be associated to severe neurodegenerative diseases 
(i.e. Friedreich’s ataxia).88 
In the context of Fe-S cluster biogenesis, it is strongly believed that Isd11 collaborates 
somehow with Nfs1 to remove sulfur from cysteines and deliver it to the scaffold proteins. 
But the precise molecular mechanism of its activity has been completely unexplored yet. 
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To elucidate it, a deeper knowledge of Isd11 structure should be achieved. This task is not 
on hand nor simple, since heterologous human Isd11 is well-known to be troublesome 
during its expression in bacterial hosts. It has been observed to be slightly more stable if its 
sequence is lacking of its first amino acids, which are related to mitochondrial import 
signal and thus useless for this study.
69
  
Against this background, the final aims of this project were: 
-  the optimization of heterologous Isd11 expression in engineered E. coli cells, through 
the precise choice of expression vectors and conditions, aimed to enhance both  
stability and solubility 
- the optimization of purification protocol, in order to make it simpler, more productive 
and cheaper  
- the study of Isd11 state of aggregation through several techniques 
This latter point could represent a first step for a wider comprehension of Isd11 role in 
association with its partner Nfs1, in order to add another little piece to the Fe-S cluster 
biosynthesis jigsaw puzzle. 
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3. RESULTS AND DISCUSSION 
 
In order to produce and study Isd11, the construct GST-ISD11(pZM96) was expressed in 
BL21 and Rosetta cells and characterized.  
Since this system was expensive and its expression not very effective, a cheaper construct 
was designed and cloned: His-tagged GST-ISD11(pETM24). Its expression in BL21 cells 
appeared to be better than the one of pZM96 system, and even better in Rosetta, but still 
not satisfying. Moreover a degradation seemed to take place when expression was 
conducted more slowly at 18°C, in order to prevent precipitation that occurred at 37°C.  
To overcome such degradation, expression of Isd11 from a thermophilic filamentous 
fungus was attempted as well. Its cloning was tried in both pETM11 (His-tag) and in 
pETM24 (His-tag plus GST, whose presence can be useful both for expression and 
solubility), but it worked only in the former one. Test for expression of His-Isd11 
(pETM11) appeared to be promising. 
 
 
3.1. Homo sapiens GST-tagged Isd11: expression in BL21 and  in Rosetta cells  
The gene encoding Isd11 already ligated to the plasmid pZM96 was provided by Dr Martin 
Friemel (University of Potsdam), who performed its expression in BL21(DE3),
74
 getting, 
however, a poor yield (around 1.5mg of protein from 12L of culture).  
Since Homo sapiens Isd11 presents quite a lot of rare codons for BL21, which on the 
contrary are supplied by Rosetta (a particular type a BL21 cell engineered for such 
codons), expression was achieved at 18°C in both types of cells, with a different protocol 
of purification. 
As expected, Rosetta cells were able to produce more Isd11. In figure 3.1, on the left, it is 
shown a picture of the SDS-PAGE after FPLC of the sample expressed in BL21: the first 
three fractions are very rich in GST, although the major part of it was separated by the 
second Protino GST/4B column (figure 3.2); the last fraction is represented by Isd11 and a 
probable product of degradation, present since lysis of cells. 
Although growth of cells was slower (in fact OD got much more time to reach the wished 
value of 0.6 and the amount of pellet after centrifugation was little) expression in Rosetta, 
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was definitely better (figure 3.1, right) and from 4 litres of cultures 1.4mg of purified Isd11 
was gotten, even if not free from the usual degraded fragment. 
Eventually a sufficient amount of protein was obtained and used for the following steps of 
characterization. 
 
          
Figure 3.1 
(left) SDS-PAGE of FPLC fraction of H. sapiens Isd11 expressed in BL21 at 18°C;  
(right) SDS-PAGE of FPLC fraction of H. sapiens Isd11 expressed in Rosetta at 18°C 
(the first space on the left of each picture is related to the marker and the MWs of some standard 
proteins are indicated in kDa) 
 
         
Figure 3.2 
(FT: flow through, W: wash, E: eluate) 
(left) SDS-PAGE of FT, W and E of the second GST column of H. sapiens Isd11 expressed in 
BL21 at 18°C; (right) SDS-PAGE of FT, W and E of the second GST column of H. sapiens Isd11 
expressed in Rosetta at 18°C 
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In this construct both cleavage site (thrombin) and affinity chromatography required by its 
tag (GST) are quite expensive. The peculiarity of GST to promote expression of bound-
proteins and enhance their solubility could justify the cost when used with such a difficult  
protein, like Isd11. In this case expression was not productive enough and other systems 
were considered. 
 
 
3.2. Homo sapiens His-tagged Isd11: gene synthesis, cloning and expression in 
BL21and in Rosetta cells 
In particular a cheaper and easier system with His-tag and TEV cleavage site was cloned 
and expressed. The vector used (pETM24) was equipped with GST, in the middle between 
His-tag and TEV site: in this way the construct could count on stability brought by GST, 
avoiding costs associated with its use as tag. 
Primers for the synthesis of inserts were designed from the sequence of human Isd11 
depleted of the first 30 amino acids (see: Methods) corresponding to the mitochondrial 
import signal, since it was observed that the resulting protein is more stable.
69
 The length 
of each primer was chosen according to the following criteria: close temperature of melting 
between them in order to set an annealing temperature which is optimal for both, high 
content of guanidine-cytosine (GC) to assure a strong interaction with the template and 
absence of even short complementary sequences in order to avoid formation of hairpins 
and loops. 
PCR worked smoothly and digestion of its products (inserts) and of vectors as well. 
Ligation had to be optimized: at first, mixture containing digested inserts was only heated 
in order to inactivate restriction enzymes and suddenly used for ligation; however 
sometimes heat inactivation was not effective or complete and thus inserts were purified 
with a suitable kit. Furthermore, since Ligase is very sensitive to amount of DNA, several 
recipes were set, following these two general guidelines: 1-10μg/ml of overall 
concentration of DNA and insert:vector molar ratio between 2 and 6 (an excess of insert is 
needed for a good ligation efficiency but a greater amount would promote multiple 
insertions). Sequencing results confirmed that the rest of the cloning worked well (fig. 3.3). 
Expression was performed at first in BL21 cells at 18°C and 37°C, with the usual protocol 
(see: Methods). At 37°C Isd11 was mainly expressed in the insoluble fraction of the 
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sample (spot at around 38 kDa in figure 3.4, left), in aggregates called inclusion bodies. At 
18°C, with overnight slow expression, a proteolytic degradation was likely to occur, since 
spots at 28kDa (maybe His-GST portion of the system) and at around 8kDa (cleaved 
Isd11) were observed. (fig. 3.4, right) 
 
 
Figure 3.3 
Sequencing results: the first row is the translation of the nucleotide sequence obtained from 
sequencing (His-tag: HHHHHH plus GST plus H. sapiens Isd11); after 252 residues it is shown the 
perfect overlapping with the amino acid sequence of human Isd11 got from database unipro.org 
  
          
Figure 3.4 
(B: before induction, A: after induction, Ain: insoluble fraction As: soluble fraction) 
 (left) SDS-PAGE of H. sapiens His-tagged Isd11 expressed in BL21 at 37°C: the circled spot is 
the protein in the insoluble fraction; (right) SDS-PAGE of H. sapiens His-tagged Isd11 expressed 
in BL21 at 18°C: circled spots represent the probable products of proteolytic degradation of the 
protein (on the marker signal of each picture some MWs of standard proteins are indicated in kDa) 
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To confirm what hypothesized was the fact that both supposed products of degradation 
were actually expected to be soluble at working pH (around 8), since such pH was not 
close to the predicted pI (6.3 for the 28kDa fragment and 10.6 for the 8kDa one, calculated 
from their sequence through ProtParam tool from expasy.org). On the contrary the proper 
protein, with pI 8.1, was correctly believed to be neutral and, thus, insoluble at working 
conditions. 
A test for expression at both temperatures and at three different pHs (6.6, 7.5 and  9) was 
performed. At these values of pH, which were intentionally not extreme and  too far from 
physiological values, some differences of solubility were observed (fig. 3.5), as expected. 
Cleaved fragments were still present, above all when expressed at 18°C, bringing to the 
consideration that such degradation is not function of pH in a significant way. 
 
 
Figure 3.5 
(B: non-inducted culture, In7: insoluble fraction: lysis and resuspension carried out at pH 7.5, Sx: 
soluble fraction: lysis and resuspension carried out at pH 6.6/7.5/9) 
SDS-PAGE showing the expression test carried out with H. sapiens His-tagged Isd11 in BL21 cells 
at 37°C for 2 and 4 hours and at 18°C overnight  
 
Degradation occurring mainly at 18°C and precipitation at 37°C characterized expression 
of the construct in Rosetta cells as well, as shown by the circled signals in figure 3.6, 
representing SDS-PAGE of insoluble and soluble fractions from expression in Rosetta. In 
this case, at 37°C it seems that a partial degradation was observed too. 
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As a consequence of such inevitable and undesired cleavage of the protein, the 
development of a hopefully more stable construct was planned, consisting on a His-tagged 
homologue of Isd11 coming from a thermophilic filamentous fungus: even if the observed 
degradation is clearly not caused by heat, proteins from thermophilic organisms present 
different types of folding and structural parameters that make them less sensitive to 
stresses in general.
75-76
 
 
 
Figure 3.6 
(Ins: insoluble fraction, Sol: soluble fraction) 
SDS-PAGE of H. sapiens His-tagged Isd11 expressed in Rosetta cells at 37°C and 18°C; the 
marker is the first on the left  
 
 
3.3. Chaetomium thermophilum Isd11: cloning and test for expression in BL21 cells 
The insert encoding Chaetomium thermophilum Isd11 was optimized and designed, bought 
and directly used in restriction enzyme digestion. Ligation of the digested insert worked 
only with the vector pETM11 (His-tag-TEV) and not with pETM24 (equipped with GST 
as well). Sequencing results are shown in figure 3.7, indicating a successful cloning of C. 
thermophilum Isd11 in pETM11. 
Since C. thermophilum Isd11 does not contain any rare codon, an expression test at 18°C 
and 37°C was performed only in BL21 cells. At both temperature, Isd11 was expressed 
still as insoluble. However expression was definitely better (as shown by large signals in 
figure 3.8 at more than 14kDa, likely corresponding to His-C. thermophilum Isd11) and 
degradation did not occur at any level. 
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The observed insolubility must be due to uncontrollable aggregation which occurs after the 
expression of the protein, since its pI (9.5) was far from the one of working conditions 
(around 8). In order to enhance solubility, cloning in pETM24 should be evaluated a 
second time. 
 
 
Figure 3.7 
Sequencing results: the first row is the translation of the nucleotide sequence obtained from 
sequencing (His-tag: HHHHHH plus TEV cleavage site: ENLYFQ\G plus C. thermophilum Isd11); 
the second row is the sequence of Isd11 got from database unipro.org which can be perfectly 
overlapped with the last 109 residues of the first one 
 
 
Figure 3.8 
(B: before induction, T: after induction, Ins: insoluble fraction, S: soluble fraction) 
SDS-PAGE of C. thermophilum His-tagged Isd11 expressed in Rosetta cells at 37°C and 18°C; the 
marker is the first on the left and the MW of a standard protein (14kDa) is indicated  
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3.4. Homo sapiens Isd11 characterization   
 
3.4.1. Circular Dichroism 
CD spectra were recorded at two different values of molarity in order to estimate 
secondary structure content of Isd11 and possible changes related to concentration. More 
importantly, thermal unfolding curves were obtained for the two samples in order to 
evaluate thermal stability. 
Samples were in FPLC buffer and, as a consequence of NaCl contribution, voltage got 
above 500V at more or less 200nm (fig. 3.9).  Therefore values below 200nm were 
considered unreliable and were not processed. Unfolding curves were obtained by 
monitoring CD at 222nm as usual. 
 
 
Figure 3.9 
Trend of  HT voltage (voltage in JASCO spectropolarimeter) is shown as function of wavelengths 
 
Spectra of 10.5 and 7.8μM samples recorded at 20°C are actually comparable (figs. 3.10-
3.11, blue lines), apart from the different intensity of signals due to a different amount of 
protein, meaning that no structural rearrangements occur in such range of concentrations. 
From deconvolution of both spectra (fig. 3.12), almost the same content in secondary 
structure was predicted: 52-54% alpha helix, 13-15% beta sheet and 33% random coil. 
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Figure 3.10 
CD spectrum of 10.5μM Isd11 sample, recorded at 20°C, in 20mM Tris pH 8, 150mM NaCl, 2mM 
TCEP, as directly obtained from purification (blue) and after a temperature scan performed to 
record thermal unfolding curve (red) 
 
 
Figure 3.11 
CD spectrum of 7.8μM Isd11 sample, recorded at 20°C, in 20mM Tris pH 8, 150mM NaCl, 2mM 
TCEP,  as directly obtained from purification (blue) and after a temperature scan performed to 
record thermal unfolding curve (red) 
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Figure 3.12 
Experimental CD spectra (green) and reconstructed ones (light blue) for 10.5μM sample (left) and 
7.8μM one (right) 
 
Online tools performing deconvolution assume that CD spectrum can be represented by a 
linear combination of its secondary structural spectra, plus a noise term (which in general 
includes the contribution of aromatic chromophores and prosthetic groups): 
 
where θλ is the CD of the protein as a function of wavelength, εi is the fraction of each 
secondary structure (i) and Sλi is the ellipticity at each wavelength of each i
th
 secondary 
structural element. Sλi can be estimated either using standard polypeptides whose 
conformations are known and have been determined by X-ray of films or by IR in solution 
or using spectra of entire proteins characterized by X-ray crystallography.
77
 
Eventually, the reconstructed CD (θλ) represents the deconvolution of the experimental one 
in its ideal constituting elements.  
 
CD spectra of both samples at 20°C were also recorded after having brought the protein to 
90°C and back to 10°C, in order to evaluate the effect of heating on its folding. As it is 
shown by figures 3.10 and 3.11 (red lines), spectra are not completely reproducible as it 
often happens after protein heat denaturation. The spectra are anyway in good agreement 
implying that the protein is thermally stable and that unfolding is mostly reversible. In fact, 
from deconvolution of both spectra the following secondary structure content results: 30% 
alpha helix, 17% beta sheet and 52% random coil. 
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Accordingly, a temperature scan from low to high temperature and vice versa shows 
similar but not identical profiles. (fig. 3.13).  
 
 
Figure 3.13 
Thermal unfolding curves of 7.8μM Isd11 sample, in 20mM Tris pH 8, 150mM NaCl, 2mM TCEP, 
obtained by scanning temperature from 10°C to 90°C (blue dots) and back from 90°C to 10°C (red 
dots) 
 
Thermal unfolding curves (direct scan, blue dots in figures 3.13-3.14) show a sigmoid 
trend, as expected, and from the inflection point of its best fitting curves (fig. 3.14, fit not 
shown in fig. 3.13) it was possible to estimate the melting temperature (Tm) of Isd11. 
No one of the two curves follows a perfect sigmoid, showing a slow increase of ellipticity 
rather than the typical initial plateaux. This is a quite common situation,
78 
usually attributed 
to secondary processes of unfolding; further CD analysis should be performed to confirm if 
this is the case. By fitting all the experimental data (red line in fig. 3.14) and only a range 
not including the starting gradual increase (green line in fig. 3.14), apparent Tm values of 
74.7°C and 73.4°C were respectively obtained. These estimated values of melting 
temperature result quite high if compared to those of other proteins in literature
79
 and 
support the same view that Isd11 is thermally stable.  
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 Figure 3.14   
Thermal unfolding curve of 10.5μM Isd11 sample, in 20mM Tris pH 8, 150mM NaCl, 2mM 
TCEP, obtained by scanning temperature from 10°C to 90°C (blue points), with best fitting curve 
of the whole range of temperature (red line) and of the range 50-90°C (green line) 
 
 
3.4.2. Nuclear Magnetic Resonance spectroscopy  
 
1D 
1
H NMR spectra of even small proteins are complex with high degree of peak 
overlap and cannot be analysed in detail in terms of tertiary structure: normally only 
gross statements about secondary or tertiary structure can be made. The spectrum of 
stably folded proteins present a good chemical shift dispersion, which clearly reflects 
that nuclei are subjected to many different and defined types of microenvironment of 
chemical screens. On the contrary, in unfolded or partially folded proteins, each 
nucleus takes random positions, whose average gives rise to its signal: averages of all 
signals result poorly spread and overlapped. Moreover, meanwhile unfolded proteins 
relax quickly, since each residue behaves almost independently, well-organised 
structures need more time. This fact leads to broader and overlapped peaks in the 
former case, to sharper ones in the latter. 
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From the recorded 1D spectrum of Isd11 (fig. 3.15) it is reasonable to infer that a 
protein is at least partially folded, as it shows sharp and well-spread peaks.  
 
 
Figure 3.15 
1D 
1
H NMR of Isd11, recorded at 25°C, in 20mM Tris pH8, 150mM NaCl, 5mM TCEP 7% D2O  
 
Addition of a second dimension still does not alleviate spectral crowding in 
1
H 
spectra. Therefore modern NMR spectroscopic studies of proteins rely on 
multidimensional experiments involving 
1
H, 
13
C and 
15
N nuclei in isotopically 
labelled proteins, since they reduce or eliminate overlap and degeneracy.  
In particular 2D 
1
H,
15
N NMR spectra of proteins provide one peak per amino acid 
(apart from proline, plus peaks related to arginine and asparagine side chains, whose 
content is known from the sequence) by correlating amide 
1
H-
15
N pairs. With further 
analysis it is possible to associate one residue of the protein sequence to each peak.  
Assignment of signals in 2D NMR spectrum of Isd11 has not been done yet. 
From the 
15
N-labeled sample of Isd11, obtained through growth in medium 
containing 
15
N-labeled ammonium sulfate, 2D 
1
H,
15
N NMR spectrum was recorded 
(fig. 3.16). According to the number, the shape and the width of peaks and from 
chemical shift dispersion, the spectrum results compatible with a pure (although 
maybe with some contaminants or degradation products) folded protein. 
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Figure 3.16 
2D 
1
H,
15
N NMR of 
15
N labelled Isd11, recorded at 25°C, in 20mM Tris pH8, 150mM NaCl, 5mM 
TCEP 7% D2O 
 
Notably, data from 2D 
1
H,
15
N NMR were used to find out average values of 
relaxation time constants T1 and T2 and, from those, the one of the rotational 
correlation time τc, in order to evaluate a possible aggregation of Isd11.  
The rotational correlation time is defined as the time needed by a particle in solution 
to rotate by one radian. When the particle is a molecule, the correlation time can be 
calculated by NMR spectroscopy, from rates of relaxation (R1 and R2, respectively 
the reverse of constants T1 and T2).
81-82
 Essentially it is a time constant defining the 
exponential trend of the correlation function G(t)=G(0)e
-t/τc
 which in turn describes 
the distribution of spins as function of time:
89
 for times much smaller than τc the spins 
do not move much and the correlation function is close to its original value (G(0)); 
for times much longer they completely change position and the correlation function 
tends to zero.  
If the molecule at issue rotates quickly (as a small one does), spin system would 
rearrange quickly, and vice versa. Therefore the correlation time is roughly 
proportional to the molecular weight of the particle and it can be used to determine 
protein size and aggregation by comparison with τc values from standard proteins.  
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After having picked up non overlapping peaks, from their values of T1 and T2 (figs. 
3.17-3.18) the average ones were obtained: 1082.7ms for T1 and 66.9ms for T2. 
Then, a rotational correlation time of 12.7ns±1ns was calculated, as previously 
described in literature.
82
 This value would indicate that this sample of Isd11 is mainly 
in its dimeric form or at least in a mixture richer of dimer than monomer.
85 
 
 
Figure 3.17 
Relaxation time constants T1 of Isd11. Since peaks have not been assigned for Isd11, 
numbers on x axis are referred to the random assignment gave by the software 
 
 
Figure 3.18 
Relaxation time constants T2 of Isd11. Since peaks have not been assigned for Isd11, 
numbers on x axis are referred to the random assignment gave by the software 
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3.4.3. Analytical Gel Filtration Chromatography 
In order to determine aggregation of Isd11, its gel filtration chromatogram was compared 
to those of other proteins for which molecular weights (MWs) and retention times of their 
monomers were known (fig. 3.19).  
Assigning a value of mass, even rough, to the retention time associated with Isd11 was not 
straightforward: in fact it seems to be in the middle between 14 and 21kDa, which cannot 
be referred to neither monomer nor dimer. 
However proteins at 20-21kDa (Josephin and HscB) have not a globular shape like the 
others, thus they should run faster through a size-exclusion column, as if they were bigger, 
and making comparisons with their retention times could be misleading. Therefore it 
cannot be excluded that Isd11 signal (the blue one in fig. 3.20) actually represents its dimer 
(20kDa) having a non-globular conformation.  
  
  
Figure 3.19 
FPLC of 66kDa Bovine Serum Albumin (BSA), 37kDa ferredoxin-NADP+ reductase (FNR), 
21kDa Josephin, 20kDa HscB, 14kDa holo-ferredoxin(Fdx), 12kDa IscA, 8.5 kDa Ubiquitin and 
Isd11. Samples were in FPLC buffer (20mM Tris pH 8, 150mM NaCl, 2mM TCEP). Proteins were 
loaded in column at different concentrations and signals were scaled in order to have roughly the 
same height: there is no correlation between intensity of peaks and concentration in the above 
chromatogram; accordingly y axis was not reported 
  
Conventional size-exclusion chromatography (SEC) distinguishes molecules of different 
size, which is not always a synonym of MW, as said above. In fact, in SEC discrimination 
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of proteins is achieved through retention times, relying on different rates of elution through 
column. But rate of elution is determined by several structural features of the sample, like 
shapes and conformations, and not only by its mass. As a consequence, a globular protein 
is seen by the column as smaller than an extended one with the same MW, and vice versa. 
For these reasons, it was not possible to infer anything clear about Isd11 aggregation from 
such a comparative analysis. 
 
3.4.4. Multi-Angle Light Scattering coupled to Size-Exclusion Chromatography 
Comparisons among proteins are still possible with SEC if they have similar profiles, 
however when structure of sample is not known, a detector directly discriminating mass, 
like those based on light scattering, would be more convenient.  
Therefore SEC-MALS was chosen as a better way to assess aggregation of Isd11: since its 
MW is known, determination of average mass could be associated with a dimeric or 
monomeric state. 
The light scattering main principles are: 1) the intensity of scattered light is proportional to 
average mass and to concentration of the effective compounds present in solution 2) the 
angular variation of the scattering is directly related to radius of samples.
83 
The phenomenon of light scattering is the result of a complex interaction between an 
incident electromagnetic radiation and the molecular structure of the scattering object. 
When the electromagnetic wave hits the discrete particle, electrons of this latter are 
perturbed and start oscillating periodically, with the same frequency as the electric field of 
the incident wave. The movement of the electron cloud produces an instantaneous 
separation of charge within the molecule: an oscillating induced dipole moment, which is 
in turn source of electromagnetic radiation, resulting in scattered light. 
A basic equation (Debye-Zimm relation) shows an angular dependence of light scattered 
by a solution of proteins or protein assemblies.
84
 Unless particle dimensions are below 1/20 
of the incident wavelength, intramolecular interferences lead to a decrease in the scattering 
intensity as the angle of observation increase, suggesting that light scattered at zero degree 
should be detected in order to get information.
83
 Since detection at 0° is impractical 
because the detector would be overloaded by the non-scattered light, a single detector 
placed as close as possible to 0° can be used. This is the principle of low-angle light 
scattering (LALS). In multiangle light scattering (MALS) the scattering intensity is 
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measured at several different angles and the molar mass is computed by extrapolation to 
0°. Extrapolation is achieved through calibration-type curves, called Debye plots. 
A typical SEC-MALS spectrum consists on peaks of samples, as commonly present in a 
chromatogram (detected as UV-absorption or as differential refractive index), and dots 
representing average molar masses (g/mol) from Debye plots. These dots usually lay on an 
imaginary flat or oblique line, indicating respectively only one product (one value of mass) 
or a distribution of products (one average mass). 
The step made by dots in Isd11 spectrum (fig. 3.20) of samples at two different 
concentrations (1mg/ml and 2mg/ml, 0.09mM and 0.18mM respectively) seems to indicate 
and partially confirms that Isd11 is in a monomer/dimer mixture, probably richer in the 
second one. In fact values computed by the processor for the two samples are 17.20kDa 
and 17.85kDa, whereas molecular weight of the cloned and expressed Isd11 is 10.31kDa. 
  
 
Figure 3.20 
SEC-MALS spectrum of 0.09mM (red) and 0.18mM (black) Isd11, in 20mM Tris pH 8, 150mM 
NaCl, 2mM TCEP. Differential refractive index (dRI) is shown as solid lines, light scattering (LS) 
as dashed lines and the average molar masses (g/mol) from the Debye plots as dots  
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4. CONCLUSION AND PERSPECTIVES      
  
Biotechnological production of Isd11 revealed to be, as expected, quite tricky. In particular 
in the case of the human protein, it seemed that a degradation easily occurred if conditions 
were not optimized. This fact would bring to the probably wrong conclusion that Isd11 is 
intrinsically unstable. On the contrary CD analysis showed that it is rather thermally stable: 
brought to 90°C it unfolds in a partially reversible way and its estimated melting 
temperature (temperature at which 50% of the protein is unfolded and 50% is still folded) 
is almost 75°C. 
The observed degradation resulting from production in E. coli cells seemed to happen 
during expression itself or suddenly after, when the protein was still into its host cell, as 
suggested by SDS PAGE gels. Therefore it could be that the cleavage was actually due to a 
proteolytic degradation, occurring by means of some proteolytic enzymes present within E. 
coli cells. Proteolysis of recombinant proteins is a serious and not uncommon problem,
86-87
 
since it reduces yields of the authentic target product. Some proteases are highly specific 
and only cleave substrates with a certain sequence. This could be the case of human Isd11, 
since two fragments were revealed by SDS PAGE gels having always the same molecular 
weights. They were present almost in any experimental condition, showing no dependence 
on pH, but only on temperature in an inverse relationship (18°C-37°C) or, more likely, on 
time in a direct one (overnight-4h), suggesting that, in this way, enzymes had more time to 
work.  
Confirming this fact, hydrolysis was not observed for C. thermophilum Isd11, which has a 
different amino acid sequence. For this reason expression of this homolog of Isd11 
appeared to be promising. However solubility of the expressed construct containing the 
protein (His tag/TEV cleavage site-Isd11) still needs to be improved: cloning and 
production of a system equipped also with GST protein is worth to be tried (using for 
examples the vector pETM24, which codes for His tag/GST/TEV cleavage site, in order to 
keep the cheaper His-tag). The high solubility and stability of GST, in fact, could implicate 
a greater solubility for the whole product as well. 
Finally the state of aggregation of human Isd11 was investigated. Results from the 
different techniques used to characterize the protein would suggest that it tends to 
aggregate under the considered conditions: analysis of SEC-MALS spectrum and the value 
of rotational correlation time got from 2D NMR indicated a mainly dimeric sample.  
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5. MATERIALS  
 
Solutions and buffers 
- Cells were purchased from Novagen. 
- Enzymes were purchased from New England Biolabs, where not differently indicated. 
- Reagents were purchased from Sigma, if not differently specified. 
- Kits used during gene synthesis and cloning were purchase from Zymo Research 
Corporation. 
- NanoDrop 2000c Spectrophotometer was from Thermo Scientific. 
- FPLC system, Akta Purifier, was from Amersham Biosciences. 
- Cary 50 Bio UV-Visible Spectrophotometer was from Varian. 
- GST-ISD11(pZM96) was provided by Dr Martin Friemel, University of Potsdam, 
Potsdam, Germany. 
- pETM11 and pETM24 was provided by Dr Robert Yan, National Institute for Medical 
Research, London, United Kingdom. 
- Proteins used for analytical FPLC were provided by members of Prof. Annalisa 
Pastore’s group. 
- Luria Broth: 10g of tryptone, 5g of yeast extract, 5g NaCl were solubilised per litre of 
H2O and the pH adjusted to pH 7.4.  The solution was then sterilised by autoclaving.  
- LB for plates: to prepare 200ml, 2g of tryptone, 1g of yeast extract, 1g NaCl, 0,2ml 1N 
NaOH and 3g of agar were solubilised in H2O. The solution was then sterilised by 
autoclaving. Ampicillin or kanamycin (Euroclone) was added in order to reach the final 
concentration of 100μg/ml and 30μg/ml respectively.  
- Ampicillin: the powder (Euroclone) was solubilised in H2O in order to reach the final 
concentration of 100mg/ml. The solution was filtered with a filter syringe (Millipore).  
- Kanamycin: the powder (Euroclone) was solubilised in H2O in order to reach the final 
concentration of 30mg/ml. The solution was filtered with a filter syringe (Millipore). 
- Tris 1M pH 8: the proper amount of powder was solubilised in H2O. The pH was 
lowered to 8 with HCl 1M.  
- NaCl 5M: the proper amount of powder was solubilised in H2O.  
- IPTG 0.5M: the powder was solubilised in H2O in order to reach the final 
concentration.  
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- EDTA 0,5M pH 8: the proper amount of powder was solubilised in H2O and solid 
NaOH were added to reach the pH 8. The solution was sterilised using an autoclave.  
- TBE: to prepare a 5X stock solution 54g of Tris, 27.5g of boric acid and 20ml of 0.5M 
EDTA pH 8 were mixed together and H2O was added in order to reach a final volume 
of 1l.  
- PBS: 8g NaCl, 0.2g KCl,1.44g Na2HPO4, 0.24g KH2PO4 were dissolved in 800ml of 
H2O. The pH was adjusted to 7.4 with HCl and then H2O was added to reach the final 
volume of 1l.  
- Lysis Buffer: 20mM Tris pH 8, 150mM NaCl, 10mM Imidazole, 2mM TCEP, 0.2% 
v/v Igepal, Lysozyme, DNAse I (Roche), complete Proteinase inhibitor (Roche), H2O 
up to the final volume. Stock solutions were prepared; TCEP, lysozyme, DNAse and 
Protein inhibitor were added fresh each time. 
- Low-salt column buffer: 20mM Tris pH 8, 150mM NaCl, 10mM Imidazole, 0.2% v/v 
Igepal, 2mM TCEP. Stock solutions were prepared; TCEP was added fresh each time. 
- High-salt column buffer: 20mM Tris pH 8, 1M NaCl, 10mM Imidazole, 2mM TCEP. 
Stock solutions were prepared; TCEP was added fresh each time. 
- Equilibrium Buffer, Wash Buffer 1 and Wash Buffer 3: low-salt column buffer. 
- Wash Buffer 2: high-salt column buffer. 
- Elution Buffer: 300mM Imidazole, 150 mM NaCl, 20mM Tris pH 8, 2mM TCEP. 
Stock solutions were prepared; TCEP was added fresh each time. 
- Dialysis Buffer: 20mM Tris pH 8, 150mM NaCl, 5mM β-mercaptoethanol, which was 
added fresh at last. 
- FPLC Buffer: 20mM Tris pH 8, 150mM NaCl, 2mM TCEP. The solution was filtered 
using 0.22μM filters (Millipore). Stock solutions were prepared; TCEP was added 
fresh each time. 
- GST-Resuspension/Wash Buffer: 1X PBS pH 8 
- GST-Elution Buffer: 50mM Tris pH 8, 10mM reduced Glutathione 
 
 
6. METHODS 
 
Every step involving cells was performed close to the flame of a Bunsen burner in order to 
restrain contaminations from the surrounding environment. 
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6.1. Gene synthesis and gBlock Gene Fragments 
 
The synthetic gene encoding Homo sapiens Isd11 was assembled by PCR with 
specific primers, using a plasmid containing part of the nucleic acid sequence of the 
human Isd11 as a template. The overall sequence (91 residues) is: 
MAASSRAQVLSLYRAMLRESKRFSAYNYRTYAVRRIRDAFRENKNVKDPVEI
QTLVNKAKRDLGVIRRQVHIGQLYSTDKLIIENRDMPRT  
The sequence used is (in capital letters are the amino acid sequence, which is made of 
the last 60 residues, in small letters the nucleic acid sequence, whose nucleotides in 
green have been chosen for primers): 
gctgtcaggaggataagagatgccttcagagaaaataaaaatgtaaaggatcctgtagaaattcaaaccctagtgaataaa    
  A  V  R  R  I  R  D  A  F  R  E  N  K  N  V  K  D  P  V  E  I  Q  T  L  V  N  K     
gccaagagagaccttggagtaattcgtcgacaggtccacattggccaactgtattcaactgacaagctgatcattgagaat 
  A  K  R  D  L  G  V   I  R  R  Q  V  H  I  G  Q  L  Y  S  T  D  K  L  I  I  E  N   
cgagacatgcccaggacctag 
  R  D  M  P  R  T -  
 
From the above nucleic acid sequence, primers were designed in order to have NcoI 
and NotI restriction sites (NcoI: CCATGG, NotI: GCGGCCGC, highlighted in grey) 
and in order to get optimized PCR parameters (similar temperature of melting of 
forward and reverse primers, high content of GC nucleotides and low probability of 
formation of hairpins and loops)  
 
Forward Primer:  
CCGC-CATG GCT GTC AGG AGG ATA AGA GAT G 
Tm: 65.7°C (54.8°C) 
GC: 56.7% 
 
Reverse Primer:  
AGTG-CGGCCGC CTA GGT CCT GGG CAT G 
Tm: 68.8°C (48.5°C) 
GC: 70.4% 
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Primers were purchased from Sigma and dissolved in H2O to yield stock solutions 
(100μM) and finally used for PCR.  
Amplification PCR was carried out using 2μl (~0.2ng) of DNA template (a plasmid 
containing nucleic acid sequence encoding Isd11), 10μl of 10X Termopol Buffer 
NEB, 2μl DMSO, 2μl dNTP mix, 1μl forward primer, 1μl reverse primer, 1.5μl of 
deep VENT DNA polymerase and 80.5μl of filtered milliQ in order to reach a final 
volume of 100μl, under the following conditions: 
-1 cycle: 95°C 5min 
-24 cycles:  95°C 30s 
 60°C 30s 
 72°C 30s 
-1 cycle: 72°C 10min  
PCR products were analysed by agarose gel electrophoresis (1% agarose gel in TBE 
buffer), using 100bp PCR Molecular Ruler as reference. The gel fragments of interest 
were isolated using a sharp blade and DNA was extracted from them following 
manufacturer’s instructions of Zymoclean Gel DNA Recovery Kit. 
DNA purity and concentration were assessed via a NanoDrop 2000c 
Spectrophotometer (Thermo Scientific). 
  
The synthetic gene encoding Chaetomium thermophilum Isd11 was purchased from 
Integrated DNA Technologies (gBlock Gene Fragments), after its sequence was 
optimized in order to avoid unspecific cleavage during the reaction of enzymatic 
digestion. The amino acid sequence of the synthetic gene of C. thermophilum Isd11 
(108 residues, plus an additional small sequence X relative to the histidine tag) is the 
following: 
X-MAARTETAQHVLSLYRQLLRQGRQFTNYNFREYAKRRTRDAFRENKD 
VQDPAQIELIQKGRQNLDMMKRQVAISQFYQLNKLVVEGGLSGKDSPGH
GETVRQKDTGWD (X=MKHHHHHHPMSDYDIPTTENLYFQGA) 
 
Considering the NcoI and NotI restriction sites at the edges of the sequence (red and 
claret), some nucleotides more (yellow) to let restriction enzymes work better and two 
stop codons (green), the nucleic acid sequence received and used was: 
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CATGCCATGGCGGCGCGTACCGAAACGGCACAACACGTCCTTTCCTTATACCG
TCAGCTGCTGCGTCAAGGCCGCCAGTTCACCAATTATAATTTCCGCGAATACG
CCAAGCGCCGTACACGCGACGCCTTTCGCGAAAACAAGGATGTGCAGGACCC
AGCGCAAATCCAAGAACTGATTCAAAAGGGCCGCCAGAATTTGGATATGATG
AAACGTCAGGTCGCTATCTCCCAATTTTATCAGTTAAATAAACTGGTGGTGGA
GGGAGGCTTAAGTGGAAAAGACAGTCCAGGTCACGGTGAAACGGTTCGCCAG
AAAGATACCGGCTGGGATTAGTAAGCGGCCGCAAACTAT 
 
 
6.2. Cloning 
 
Digestion 
Digestions were carried out using the restriction enzymes NcoI and NotI.  
A 30μl-reaction was performed for the PCR products with the following conditions: 
3μl of NEBuffer 3.1, 0.5μl of each enzyme, 1μg of DNA made up to a final volume of 
30 μl with milliQ water. The mixture was incubated at 37°C overnight.  
An overnight 10.4μl-reaction at 37°C was settled for the gBlock into the PCR machine 
in order to limit evaporation and condensation on the cap of the eppendorf, with the 
following recipe: 600ng of DNA, 1μl of NEBbuffer 3.1 and 0.2μl  of each enzyme, 
made up to a final volume of 10 μl with milliQ water. 
Vectors (pETM11 and pETM24) were digested in the same conditions of the above 
30μl-reaction into the PCR machine.  
Digestion plasmids were  separated by agarose gel electrophoresis (1%), using SYBR 
safe dye to visual the DNA fragments The digested DNA fragments were cut from the 
gel using a sharp blade and the DNA was extracted using the  Zymoclean Gel DNA 
Recovery Kit following the manufactures instructions. 
Digested PCR products were purified following instructions of the DNA 
Clean&Concentrator -5 kit. 
Purity and concentration of both inserts and vectors were assessed via a NanoDrop 
2000c Spectrophotometer. 
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Ligation 
Ligation of digested PCR product and plasmid was performed with T4 DNA Ligase, 
following manufacturer’s guidelines as regards total amount of DNA in solution and 
molar ratio between insert and vector. The resulting reaction conditions were: room 
temperature for 1 hour in total volume of 20μl, composed as it follows: 2μl of T4 
DNA Ligase Buffer, 1μl of enzyme, 1μl of digested plasmid and 12-16μl of digested 
PCR product (plus 0-4μl of filtered milliQ, according to concentration of insert). 
Enzyme was added at the end and the mixture of reaction was kept on ice until then.  
 
Transformation of DH5α E. coli competent cells  
10-100ng of ligated plasmid was added to 30-50μl of DH5α E. coli chemically 
competent cells. After 30 minutes of incubation in ice, competent cells were 
transformed by heat shock in a water bath at 42°C for 30 seconds, left again in ice for 
2 minutes and incubated in 250μl of LB for 1h at 37°C.  
  
Plating 
100-300μl of the transformed cells were plated on a LB-agar plate with kanamycin or 
ampicillin, depending on the plasmid resistance (ampicillin only in the case of GST-
tagged Isd11), and spread with a sterile spatula. The same amount of cells transformed 
with the digested plasmid was occasionally plated as negative control, to check the 
fulfilment of digestion. All the plates were incubated at 37°C overnight.  
  
Inoculation  
Single colonies were picked, inoculated in 50ml of LB containing kanamycin 
(30μg/ml) or ampicillin (100μg/ml) and incubated at 37°C, 220 rpm, overnight.  
 
Glycerol stock 
After the overnight growth, 500μl of culture were mixed with 300μl of 80% glycerol, 
flash frozen in liquid N2 or on dry ice and then stored at -80°C. A glycerol stock can 
be directly inoculated, skipping steps of transformation and plating. 
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Minipreps  
After the overnight growth, cells were centrifuged at 13000g for 10 minutes and the 
plasmid DNA was extracted using Zymo Miniprep Kit following the manufactures 
instructions. The sample was eluted using 20-30μl filtered milliQ.  
The plasmid DNA concentration was measured using the Nanodrop.  
Plasmids containing the gene of interest were sequenced in both forward and reverse 
directions with T7 promoter/reverse primers. Sequencing was performed by Beckman 
Coulter Genomics company. 
 
 
6.3. Protein expression  
 
Transformation of E. coli BL21 (DE3), E. coli BL21 (DE3) pLysS or Rosetta (DE3) 
competent cells 
E. coli BL21 (DE3), E. coli BL21 (DE3) pLysS and Rosetta (DE3) competent cells 
were transformed with Isd11 expression plasmids as described in Section 2.2, using the 
appropriate antibiotics. 
 
Plating 
50μl of the transformed cells were plated on a LB-agar plate with kanamycin or 
ampicillin, depending on the plasmid resistance, and spread with a sterile spatula. 
Plates were incubated at 37°C overnight.  
 
Inoculation and growth of cells 
A single colony was used to inoculate a pre-culture consisting of 50ml of LB 
containing kanamycin (30μg/ml) or ampicillin (100μg/ml) and incubated at 37°C, 220 
rpm overnight. The pre-culture was used to inoculate 500 ml of fresh LB containing the 
appropriate antibiotics in a 2 L flask to give a starting optical density at 600nm (OD600) 
of 0.1. The cells were incubated at 37°C, with shaking at 220 rpm. When the OD600 
reached a value of 0.6-0.8, protein expression was induced by adding IPTG to a final 
concentration of 0.1mM or 0.5mM. Expression was either carried out at 37°C for 4h or 
at 18°C overnight. 
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The cells were harvested by centrifugation (6000g at 4°C for 15 minutes). The resulting 
supernatant was resuspended in Lysis Buffer and store at -80°C until further 
purification steps were carried out. 
 
Glycerol stock 
Glycerol stocks of E. coli BL21 (DE3) or Rosetta (DE3) cells were prepared as 
described in Section 6.2. 
 
Small scale protein expression  
To test for protein expression, small scale growth cultures (50 ml) were grown as 
described previously. 1 ml samples of the cells were taken before and after induction 
with IPTG. They were subsequently centrifuged at 13000g and the supernatants were 
discarded. The cell pellets were resuspended in 300μl of B-PER (Thermo Scientific) or 
BugBuster (Merck) and vortexed to lyse the cells. 10 µl were taken and run on SDS-
PAGE to analyse the total cell extracts before and after induction. To assess solubility 
of the proteins expressed, the total cell extracts were centrifuged at 13000g to separate 
the inclusion bodies from the soluble proteins. The supernatant (soluble fraction) was 
carefully removed and the remaining pellet was resuspended in 100μl of a protein 
extraction reagent (insoluble fraction). Together with the total cell extracts, the soluble 
and insoluble fractions were analysed by SDS-PAGE 
To assess the effect of pH on protein solubility during cell lysis, this procedure was 
repeated where the pH of BugBuster/BPER-II was adjusted to  pH 6.5, 7.5 and 9 prior 
to cell lysis. 
  
 
6.4. Protein purification 
 
6.4.1. Purification of a His-tagged protein having a TEV cleavage site  
 
Affinity chromatography  
Cell pellets were thawed, sonicated on ice for 3 minutes at 50W, 50% pulse cycle, 
and centrifuged at 39000g at 4°C for 30 minutes. Meanwhile 1ml of Ni-NTA agarose 
 50 
 
resin (Biorad), per litre of culture were put in a column, washed with milliQ and pre-
equilibrated by washing with 10 column volumes (CV) of Equilibrium Buffer.  
Debris derived from centrifugation were discarded and the supernatant was loaded on 
the column and mixed with the resin on a rotary mixer, at 4°C for 1h, in order to 
allow the histidine tag (a chain of 6 histidines) present at the N-terminus of the 
protein to bind the resin.  
After that, the column was opened and the flow through (FT) containing unbound 
protein was collected; then the resin was washed with 10 CV of Wash Buffer 1 (W1), 
10 CV of Wash Buffer 2 (W2) and 10 CV of Wash Buffer 3 (W3). The resin was 
resuspended with 4-5 column volumes of Elution Buffer and incubated at 4°C for 30 
minutes on a rotary mixer to elute the protein. The eluate containing the protein was 
collected (E). 
To confirm that the bulk of the protein had been eluted, the eluate was collected in 
1ml fractions and their protein content was crudely estimated by mixing 5µl with 
100µl of Bradford reagent (Biorad). Typically, the first few fractions reacted with the 
reagent to give an intense blue colour, which became much less intense once the bulk 
of the protein was eluted. If necessary, the elution step was repeated. 
Collected fractions (FT, W1, W2, W3 and E) were analysed by SDS-PAGE. 
After each cycle of purification, the column was re-equilibrated with 10 CV of 
Elution Buffer, 10 CV of Wash Buffer 1 and 10 CV of H2O. It was stored in the 
fridge at 4°C, with the resin resuspended in water, if needed the day after, or in 20 % 
ethanol, if stored for a longer time, in order to avoid proliferation of microorganisms. 
 
His-tag removal 
1-2 1ml aliquots of 15μM  TEV protease  (produced in-house)  per litre of culture 
expressed were added to the eluate, which was subsequently  dialysed at 4°C for 3-4 
hours against 2l of Dialysis Buffer and then overnight against a further 2l of fresh 
Dialysis Buffer. A dialysis membrane with a MW cut-off (in this case 3000kDa) of at 
least 1/3 of the protein MW was used. 
 
Affinity chromatography and Gelfiltration 
The day after the dialysed solution was analysed by SDS-PAGE. Then it was loaded 
again on a Ni-NTA column and mixed at 4°C for 15 minutes, in order to let the 
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cleaved His-tag bind the resin, while the protein remained in the soluble fraction. The 
protein was eluted and concentrated up to a volume of 0.5-1ml by centrifugation at 
500g at 4°C, using a Vivaspin20 (Sartorius Stedim biotech) with a MW cut-off of at 
least 1/3 of the protein MW. 
The solution was then purified by gelfiltration. The sample was injected in the FPLC 
column using a syringe. The flow rate was kept at 1ml/min, the pressure at 0.5 MPa 
and the wavelengths 280nm (aromatic amino acids), 260nm (nucleotides) and 215nm 
(peptide bond) were monitored. The eluate was collected in 1-1.5ml fractions. 
Identity and purity of fractions was checked by SDS-PAGE. 
 
Measurement of protein concentration  
The protein concentration was measured both through Bradford assay and through 
Lambert and Beer’s law, A=εcd (ε: molar extinction coefficient of the protein, c: 
molar concentration, d: length of the optic pathway in cm): the absorbance at 280 nm 
was monitored by a Cary 50 Bio UV-Visible Spectrophotometer and ε was estimated 
using ProtParam tool from expasy.org. 
Bradford assay was carried out following the usual protocol,
73
 using BSA as standard 
protein and Coomassie Brilliant Blue from Bio-Rad. It was performed because Isd11 
has no tryptophan  residues, which makes the predicted value for its molar extinction 
coefficient less reliable. 
 
Bradford assay is a colorimetric protein assay, based on the absorbance shift of the dye 
Coomassie Brilliant Blue: the binding with proteins causes a shift in the absorption 
maximum of the dye from 465 (red) to 595 nm (blue).
73 
A greater absorption imply a 
greater amount of proteins, thus absorbance at 595nm is monitored. To correlate 
concentration to absorbance a calibration curve is build according to values recorded 
for a standard protein (BSA).  
 
6.4.2. Purification of GST-tagged protein having a Thrombin cleavage site 
 
 Affinity chromatography 
Cell pellets were thawed, sonicated on ice for 3 minutes at 50W, 50% pulse cycle, 
and centrifuged at 39000g at 4°C for 30 minutes. A column containing Protino 
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Glutathione Agarose 4B (Macherey-Nagel) was washed with 10 column volumes of 
GST-Resuspension/Wash Buffer and then mixed at 4°C for 1h with the supernatant 
derived from centrifugation, in order to let the GST tag of the protein to bind the 
resin. After that, when the matrix was settled down, the flow through (FT) was 
collected, the matrix was washed with 10-20 volumes of GST-Resuspension/Wash 
Buffer and washes (W) were collected as well. The column was closed and the resin 
was incubated with 4 column volumes of GST-Elution Buffer for 30 minutes, in order 
to let the protein bind the resin thanks to its GST tag. The column was opened and the 
eluate containing the protein was collected (E). 
Collected fractions (FT, W and E) were analysed by SDS-PAGE. 
After each use, the column was regenerated following a basic cleaning protocol, 
consisting in: 10 column volumes of 100 mM Tris-HCl, 0.5 M NaCl, pH 8.5 and 10 
volumes of 10 mM sodium acetate, 0.5 M NaCl, pH 4.5. Both washes were repeated 
twice. Finally the column was washed with 5 volumes of PBS and stored at 4°C with 
water, if for a short time, or with ethanol, if for a longer one. 
 
Thrombin cleavage 
Thrombin cleavage was performed by adding 10μl of 100U/ml Thrombin (Sigma) per 
litre of initial culture (i.e. 1U of thrombin per litre of culture; thrombin has roughly 
4500units/mg), while dialysing the sample at 4°C as above described: for 3-4 hours in 
2l of Dialysis Buffer and then overnight in 2l of fresh Dialysis Buffer. A dialysis 
membrane with a MW cut-off of at least 1/3 of the protein MW was used. 
 
Affinity chromatography and Gelfiltration  
The day after the dialysed solution was analysed by SDS-PAGE. Then it was loaded 
again on a Protino GST/4B column and mixed at 4°C for 45 minutes, in order to let 
the cleaved GST-tag bind the resin, while the protein remained in the soluble fraction. 
The protein was eluted with the flow through and with 10-20 volumes of GST-
Resuspension/Wash Buffer and concentrated up to a volume of 0.5-1ml by 
centrifugation at 5000g at 4°C, using Vivaspin20 (Sartorius Stedim biotech) with a 
MW cut-off of at least 1/3 of the protein MW. 
Cleaved GST was eluted with 10 volumes of GST-Elution Buffer and collected. Both 
samples (FT+W and E) were analysed by SDS-PAGE. 
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The protein was purified by gelfiltration. The sample was injected in the FPLC 
column using a syringe. The flow rate was kept at 1ml/min, the pressure at 0.5 MPa 
and the wavelengths 280nm (aromatic amino acids), 260nm (nucleotides) and 215nm 
(peptide bond) were monitored. The eluate was collected in 1-1.5ml fractions. After 
checking identity and purity by SDS-PAGE, fractions were concentrated by 
centrifugation in order to get 1.5ml of 1mg/ml of sample, which was stored at 4°C 
before further analysis. 
 
Measurement of protein concentration 
Measure of protein concentration was performed exactly as above described for His-
tagged protein having a TEV cleavage site. 
 
 
6.5. Electrophoresis 
 
6.5.1. Agarose gel electrophoresis 
1g of agarose powder was dissolved in 50ml of TBE using the microwave to prepare 
a 2% agarose gel. 2.5μl of  SYBR Safe DNA gel stain 50X (Invitrogen) were added 
and the solution was poured in the gel mould. Samples were simply prepared by 
adding the proper amount of Blue Loading Dye 6X (Promega) and were loaded on the 
solidified gel. At the end of the run the gel was exposed to UV light on a 
transilluminator to detect DNA. 
 
6.5.2. Polyacrylamide gel electrophoresis  
Polyacrylamide gels, NuPAGE Novex Bis-Tris 4-12% Gel, were purchased from Life 
Technologies. 10-15μl of each samples were added to the same volume of Laemmli 
SDS sample Buffer 2X, loaded in separate wells and run for 35 minutes at 200V. 
SeeBlue Prestain (Novex) was used as marker. After the run, gels were stained with 
Instant Blue (Expedeon) and then put in water to remove some background before 
taking a picture of it. 
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6.6. Circular Dichroism 
 
Samples for CD spectroscopy were prepared by dilution of the sample got from FPLC. 
Final concentrations (113 and 80 μg/ml, 10.5 and 7.8 μM respectively) were 
determined through Bradford assay.  
CD spectra were recorded at 20°C on a Jasco J-715 spectropolarimeter, using fused 
silica cuvettes of 0.1 cm path length (Hellma, Jena, Germany) in the wavelength range 
197-260 nm.  
Secondary structure content was estimated using the Dichroweb server 
(dicroweb.cryst.bbk.ac.uk/html/home.shtml) using either the K2D or Selcon 3 
algorithm using a standard reference set 4 (references for Selcon3 and K2D: see 
dichroweb.cryst.bbk.ac.uk/html/references.shtml). Thermal unfolding curves were 
obtained by monitoring the CD at 222 nm at a heating rate of 1°C/min over the 
temperature range 10-90°C. The transition mid-point temperatures were estimated by 
fitting the data to a sigmoidal curve defined by Boltzamnn equation, using OriginPro 
8. 
 
 
6.7. Nuclear Magnetic Resonance spectroscopy  
 
NMR spectrum was recorded at 25°C on Bruker Avance III spectrometer with TCI 
Cryoprobe operating at a 
1
H frequency of 600 MHz. 
1
H 1D, 
15
N HSQC experiments 
were recorded at 25°C. 
15
N labelled Isd11 was in 20mM Tris pH8, 150mM NaCl, 
5mMTCEP, 7% D2O and it was provided by Dr. Martin Friemel. To express 
15
N 
labelled protein, M9 minimal media was used in place of LB, using 
15
N labelled 
ammonium sulfate as the sole nitrogen source. 
15
N T1 and T2 relaxation data were 
recorded as described in literature.
80-81
 T1 and T2 were calculated using the two 
parameter fit in Rate Analysis module in NMRView (One Moon Scientific). 
 
 
6.8. Analytical Gel Filtration Chromatography 
 
Analytical gel filtration was carried out on Akta Purifier using a 10/30 superdex 200 
analytical column on Isd11 and a cohort of proteins of know structures and oligomeric 
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states: BSA, ferredoxin, ferredoxin-NADP+ reductase, HscB, IscA, Josephin, 
ubiquitin. 
Each sample was injected in the FPLC column using a syringe. The flow rate was kept 
at 0.5ml/min, the pressure at 1.8 MPa and the wavelengths 280nm (aromatic amino 
acids), 260nm (nucleotides) and 215nm (peptide bond) were monitored.  
 
6.9. Multi-Angle Light Scattering coupled to Size-Exclusion Chromatography 
 
Isd11 fresh from gel filtration was filtered through a 0.2 μm syringe filter prior to 
analysis.  
The SEC/MALS system consisted of DAWN-HELEOS laser photometer and an 
OPTILAB-rEX differential refractometer (dRI) (Wyatt). The column was Superdex 
200 Increase (GE Healthcare).  
Data acquisition and processing were carried out by Dr I Taylor of the National 
Institute for Medical Research using the ASTRA software version 5.1 
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